Public SEC Form D records
Biotech Series A Form D filings - November 2026
This page lists the 7 matching Form D filings FormDFlow has indexed and tagged from public SEC EDGAR records for Biotech-tagged issuers at a FormDFlow-inferred Series A stage in November 2026 - a filtered subset, not every matching Form D filed, and not a ranked, curated, or recommended selection. FormDFlow surfaces public-disclosure data from SEC EDGAR. Nothing here is investment advice.
- Filings
- 7
- Issuers
- 7
- Combined disclosed
- $30.2M
Directory links
Filing records
7 crawlable filing links in this facet.
- ABVC BIOPHARMA, INC.November 10, 2026 / Reg D 506(b) / CA$3.4M
- Aprexis, Inc.November 10, 2026 / Reg D 506(b) / VT$2.2M
- NBO Pharma Inc.November 9, 2026 / Reg D 506(c) / NY$7.0M
- ASCENDIA PHARMACEUTICALS, INC.November 6, 2026 / Reg D 506(b) / NJ$4.1M
- BridgeHealth Pharmaceuticals, Inc.November 5, 2026 / Reg D 506(b) / MA$3.5M
- Araceli Biosciences Inc.November 3, 2026 / Reg D 506(b) / OR$4.5M
- EVIA Life Sciences Inc.November 2, 2026 / Reg D 506(b)$5.5M